Can DAA therapy for HCV reactivate HBV in coinfected patients?
Release Date:
In this Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Can DAA therapy for HCV reactivate HBV in coinfected patients?